United States Neurological Disorder Drugs Market Report 2017

  • ID:PD014922
  • January 2017
  • QY Research
                          

The Global Neurological Disorder Drugs Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure, consumption value and sale price. The key companies of the Neurological Disorder Drugs market, manufacturers, distributors along with the latest development trends and Forecasts are detailed in the Report.

Notes:
Sales, means the sales volume of Neurological Disorder Drugs
Revenue, means the sales value of Neurological Disorder Drugs

This report studies sales (consumption) of Neurological Disorder Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

  • Novartis AG
  • GlaxoSmithKline plc
  • Merck & Co.
  • Bayer AG
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche Ltd.

Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Antipsychotic
  • Hypnotic & Sedative
  • Analgesics
  • Anticoagulants
  • Others
Split by applications, this report focuses on sales, market share and growth rate of Neurological Disorder Drugs in each application, can be divided into
  • Hospital
  • Clinic
  • Home

Table of Contents - Snapshot
1 Overview
2 United States Competition by Manufacturers
3 United States Sales (Volume) and Revenue (Value) by States (2011-2016)
4 United States Sales (Volume) and Revenue (Value) by Type (2011-2016)
5 United States Sales (Volume) by Application (2011-2016)
6 United States Manufacturers Profiles/Analysis
7 Manufacturing Cost Analysis
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
10 Market Effect Factors Analysis
11 United States Market Forecast (2016-2021)
12 Research Findings and Conclusion
13 Appendix

Table of Contents - Guidelines

United States Neurological Disorder Drugs Market Report 2017
1 Neurological Disorder Drugs Overview
1.1 Product Overview and Scope
1.2 Classification
1.2.1 Antipsychotic
1.2.2 Hypnotic & Sedative
1.2.3 Analgesics
1.2.4 Anticoagulants
1.2.5 Others
1.3 Application
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Home
1.4 United States Market Size Sales (Volume) and Revenue (Value) (2011-2021)
1.4.1 United States Neurological Disorder Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Neurological Disorder Drugs Revenue and Growth Rate (2011-2021)

2 United States Neurological Disorder Drugs Competition by Manufacturers
2.1 United States Neurological Disorder Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Neurological Disorder Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Neurological Disorder Drugs Average Price by Manufactures (2015 and 2016)
2.4 Neurological Disorder Drugs Market Competitive Situation and Trends
2.4.1 Neurological Disorder Drugs Market Concentration Rate
2.4.2 Neurological Disorder Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Neurological Disorder Drugs Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Neurological Disorder Drugs Sales and Market Share by States (2011-2016)
3.2 United States Neurological Disorder Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Neurological Disorder Drugs Price by States (2011-2016)

4 United States Neurological Disorder Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Neurological Disorder Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Neurological Disorder Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Neurological Disorder Drugs Price by Type (2011-2016)
4.4 United States Neurological Disorder Drugs Sales Growth Rate by Type (2011-2016)

5 United States Neurological Disorder Drugs Sales (Volume) by Application (2011-2016)
5.1 United States Neurological Disorder Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Neurological Disorder Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Neurological Disorder Drugs Manufacturers Profiles/Analysis
6.1 Novartis AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Neurological Disorder Drugs Product Type, Application and Specification
6.1.2.1 Antipsychotic
6.1.2.2 Hypnotic & Sedative
6.1.3 Novartis AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc
6.2.2 Neurological Disorder Drugs Product Type, Application and Specification
6.2.2.1 Antipsychotic
6.2.2.2 Hypnotic & Sedative
6.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Merck & Co.
6.3.2 Neurological Disorder Drugs Product Type, Application and Specification
6.3.2.1 Antipsychotic
6.3.2.2 Hypnotic & Sedative
6.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Bayer AG
6.4.2 Neurological Disorder Drugs Product Type, Application and Specification
6.4.2.1 Antipsychotic
6.4.2.2 Hypnotic & Sedative
6.4.3 Bayer AG Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Neurological Disorder Drugs Product Type, Application and Specification
6.5.2.1 Antipsychotic
6.5.2.2 Hypnotic & Sedative
6.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim GmbH
6.6.2 Neurological Disorder Drugs Product Type, Application and Specification
6.6.2.1 Antipsychotic
6.6.2.2 Hypnotic & Sedative
6.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceutical Industries Ltd.
6.7.2 Neurological Disorder Drugs Product Type, Application and Specification
6.7.2.1 Antipsychotic
6.7.2.2 Hypnotic & Sedative
6.7.3 Teva Pharmaceutical Industries Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview
6.8 F. Hoffmann-La Roche Ltd.
6.8.2 Neurological Disorder Drugs Product Type, Application and Specification
6.8.2.1 Antipsychotic
6.8.2.2 Hypnotic & Sedative
6.8.3 F. Hoffmann-La Roche Ltd. Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview

7 Neurological Disorder Drugs Manufacturing Cost Analysis
7.1 Neurological Disorder Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Neurological Disorder Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Neurological Disorder Drugs Market Forecast (2016-2021)
11.1 United States Neurological Disorder Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Neurological Disorder Drugs Sales Forecast by Type (2016-2021)
11.3 United States Neurological Disorder Drugs Sales Forecast by Application (2016-2021)
11.4 Neurological Disorder Drugs Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source
 

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..